[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335890-105":59,"doc-detail-335890-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","isolating-the-effect-of-confounding-from-the-observed-survival-benefit-of-screening-participants-a-methodological-approach-illustrated-by-data-from-the-german-mammography-screening-programme","Isolating the effect of confounding from the observed survival benefit of screening participants - a methodological approach illustrated by data from the German mammography screening programme","","Mammography screening programmes aim to reduce breast cancer mortality by moving diagnoses to earlier stages, but effectiveness is hard to assess using observational comparisons between participants and non-participants due to self-selection confounding and related biases. This article proposes a routine-data method to quantify the contribution of confounding in breast-cancer survival analyses, using contrasts across screen-detected, interval, and non-participant groups to eliminate stage shift, lead time, and length time bias.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/isolating-the-effect-of-confounding-from-the-observed-survival-benefit-of-screening-participants-a-methodological-approach-illustrated-by-data-from-the-german-mammography-screening-programme/335890/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/isolating-the-effect-of-confounding-from-the-observed-survival-benefit-of-screening-participants-a-methodological-approach-illustrated-by-data-from-the-german-mammography-screening-programme/335890.png","ImageObject",300,407,{"name":92,"@type":93},"Logic","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why is it difficult to evaluate the effectiveness of mammography screening programmes using observational data?","Question",{"text":113,"@type":114},"Effectiveness is difficult to assess because participant–non-participant comparisons are influenced by self-selection into screening, which introduces confounding and is hard to control. Other biases related to screening timing and detection also affect observed survival.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does the study estimate the contribution of confounding?",{"text":118,"@type":114},"The study uses routine data from the Cancer Registry of North Rhine-Westphalia and compares outcomes across non-participants, screen-detected participants, and participants with interval cancers. By using contrasts and a negative-control-like outcome assumption, it removes or minimises stage shift, lead time, and length time bias to isolate confounding effects.",{"name":120,"@type":111,"acceptedAnswer":121},"What survival benefit patterns are observed across different comparisons?",{"text":122,"@type":114},"Participants with screen-detected cancer show a lower hazard of breast-cancer death than non-participants, but the estimate is biased by lead and length time bias and confounding. When comparing interval cancers to non-participants, the advantage is smaller; considering mortality from causes other than breast cancer further minimises length time bias, yet a residual survival advantage remains attributable to confounding.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},335890,1790193475,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":105,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},1099513958762,"https://ap-avatar.wpscdn.com/avatar/1000023916a998db790?x-image-process=image/resize,m_fixed,w_180,h_180&k=1784791008015729253","Buschmann et al. BMC Medicine (2024) 22:43 [https://doi.org/10.1186/s12916-024-03258-6](https://doi.org/10.1186/s12916-024-03258-6)  \nBMC Medicine  \n RESEARCH ARTICLE Open Access  \nIsolating the effect of confounding  \nfrom the observed survival benefit of screening participants—a methodological approach illustrated by data from the German mammography screening programme  \nLaura Buschmann 1*† , Ina Wellmann2†, Nadine Bonberg1, Jürgen Wellmann1 , Hans‑Werner Hense 1 ,  \nAndré Karch 1† and Heike Minnerup1†  \nAbstract  \nBackground Mammography screening programmes (MSP) aim to reduce breast cancer mortality by shifting diagno‑ ses to earlier stages. However, it is difficult to evaluate the effectiveness of current MSP because analyses can only rely on observational data, comparing women who participate in screening with women who do not. These comparisons are subject to several biases: one of the most important is self‑selection into the MSP, which introduces confounding and is difficult to control for. Here, we propose an approach to quantify confounding based on breast cancer survival analyses using readily available routine data sources.  \nMethods Using data from the Cancer Registry of North Rhine‑Westphalia, Germany, we estimate the relative con‑ tribution of confounding to the observed survival benefit of participants of the German MSP. This is accomplished by comparing non‑participants, participants with screen‑detected and participants with interval breast cancers for the endpoints “death from breast cancer” and “death from all causes other than breast cancer” —the latter being assumed to be unrelated to any MSP effect. By using different contrasts, we eliminate the effects of stage shift, lead and length time bias. The association of breast cancer detection mode with survival is analysed using Cox models in 68,230 women, aged 50–69 years, with breast cancer diagnosed in 2006–2014 and followed up until 2018.  \nResults The hazard of dying from breast cancer was lower in participants with screen‑detected cancer than in non‑ participants (HR = 0 . 21, 95% CI: 0 .20–0. 22), but biased by lead and length time bias, and confounding. When com‑ paring participants with interval cancers and non‑participants, the survival advantage was considerably smaller  \n(HR = 0 . 62, 95% CI: 0 .58–0. 66), due to the elimination of stage shift and lead time bias. Finally, considering only mor‑ tality from causes other than breast cancer in the latter comparison, length time bias was minimised, but a survival advantage was still present (HR = 0 . 63, 95% CI: 0 .56–0. 70), which we attribute to confounding.  \n†Laura Buschmann, Ina Wellmann, André Karch, and Heike Minnerup contributed equally as first/senior authors.  \n*Correspondence:  \nLaura Buschmann  \n[laura.buschmann@ukmuenster.de](laura.buschmann@ukmuenster.de)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[. The Creative Commons Public Domain Dedication waiver (](http://creativecommons.org/licenses/by/4.0/. T","cbCaiuZ2GXeqKeqz","https://ap.wps.com/l/cbCaiuZ2GXeqKeqz","pdf",1846612,"English","# Abstract\n# Background\n# Methods\n# Results\n# Conclusions\n# Keywords","[{\"question\":\"Why is it difficult to evaluate the effectiveness of mammography screening programmes using observational data?\",\"answer\":\"Effectiveness is difficult to assess because participant–non-participant comparisons are influenced by self-selection into screening, which introduces confounding and is hard to control. Other biases related to screening timing and detection also affect observed survival.\"},{\"question\":\"How does the study estimate the contribution of confounding?\",\"answer\":\"The study uses routine data from the Cancer Registry of North Rhine-Westphalia and compares outcomes across non-participants, screen-detected participants, and participants with interval cancers. By using contrasts and a negative-control-like outcome assumption, it removes or minimises stage shift, lead time, and length time bias to isolate confounding effects.\"},{\"question\":\"What survival benefit patterns are observed across different comparisons?\",\"answer\":\"Participants with screen-detected cancer show a lower hazard of breast-cancer death than non-participants, but the estimate is biased by lead and length time bias and confounding. When comparing interval cancers to non-participants, the advantage is smaller; considering mortality from causes other than breast cancer further minimises length time bias, yet a residual survival advantage remains attributable to confounding.\"}]","Isolating the effect of confounding from the observed survival benefit of screening participants - a methodological approach illustrated by data from the German mammography screening programme | PDF",1790012750,33]